|
End-of-day quote
Shenzhen S.E.
09/09/2026
|
5-day change | 1st Jan Change | ||
| 34.95 CNY | -1.91% |
|
-3.11% | +4.17% |
| 04/09 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 04/09 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 1.57TCr 234.05Cr 200.76Cr 189.14Cr 172.39Cr 322.41Cr 22TCr 324.27Cr 2.24TCr 865.48Cr 11TCr 878.54Cr 859.58Cr 36TCr | P/E 2026 * |
30.1x | P/E 2027 * | -152x |
|---|---|---|---|---|---|
| Enterprise Value | 1.57TCr 234.05Cr 200.76Cr 189.14Cr 172.39Cr 322.41Cr 22TCr 324.27Cr 2.24TCr 865.48Cr 11TCr 878.54Cr 859.58Cr 36TCr | EV / Sales 2026 * |
14.5x | EV / Sales 2027 * | 12.5x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.91% | ||
| 1 week | -3.11% | ||
| Current month | -3.21% | ||
| 1 month | -8.00% | ||
| 3 months | +0.69% | ||
| 6 months | +9.49% | ||
| Current year | +4.17% |
| 1 week | 34.9 |  | 38.8 |
| 1 month | 34.13 | | 40.2 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 69.28 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
Liang Wen Huang
CHM | Chairman | 50 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/01/26 | Buy | Director | 4,200 | 0.0010% | ||
| 24/11/25 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.91% | -3.11% | -47.36% | +79.78% | 238.11Cr | |
| -1.11% | -3.32% | +17.96% | +64.97% | 4.77TCr | |
| -1.06% | -5.77% | +37.73% | +115.68% | 4.02TCr | |
| -1.58% | -3.46% | +11.66% | +79.48% | 1.21TCr | |
| -1.51% | -4.21% | -11.56% | +9.52% | 1.18TCr | |
| +0.38% | -1.32% | +21.40% | +137.27% | 915.56Cr | |
| 0.00% | -4.04% | +21.19% | +33.90% | 734.33Cr | |
| -2.95% | -5.33% | +32.45% | -15.96% | 738.84Cr | |
| -1.60% | -1.43% | +18.67% | +213.45% | 736.58Cr | |
| +1.32% | -1.19% | -46.13% | +22.77% | 513.21Cr | |
| Average | -1.00% | -2.20% | +5.60% | +74.09% | 1.51TCr | |
| Weighted average by Cap. | -1.06% | -2.70% | +18.32% | +80.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.53TCr 22Cr 154.3Cr 60Cr 781.84Cr 61Cr 59Cr 2.47TCr | 125.8Cr 19Cr 16Cr 15Cr 14Cr 26Cr 1.79TCr 26Cr 179.73Cr 69Cr 910.7Cr 71Cr 69Cr 2.88TCr |
| Net income | 53Cr 7.85Cr 6.74Cr 6.35Cr 5.78Cr 11Cr 747.1Cr 11Cr 75Cr 29Cr 380.79Cr 29Cr 29Cr 1.2TCr | -10Cr -1.52Cr -1.31Cr -1.23Cr -1.12Cr -2.1Cr -144.87Cr -2.11Cr -15Cr -5.63Cr -74Cr -5.72Cr -5.59Cr -233.5Cr |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | CN¥34.95 | -1.91% | 50,30,471 |
| 08/26/08 | CN¥35.63 | -0.95% | 62,79,493 |
| 07/26/07 | CN¥35.97 | +1.07% | 59,75,692 |
| 04/26/04 | CN¥35.59 | -2.76% | 1,35,11,136 |
| 03/26/03 | CN¥36.60 | -0.81% | 63,59,891 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
